Adenomyosis: a systematic review of medical treatment

References

• Struble J, Reid S, Bedaiwy MA. Adenomyosis: a clinical review of a challenging gynecologic condition. J Minim Invasive Gynecol 2016;23:164–85
   PubMed Web of Science ®Google Scholar
• Mais V, Angioni S, Cossu E, et al. Laparoscopic treatment of a cystic adenomyoma. Giorn It Ost Gin 2005;27:398–9
   Google Scholar
• Melis GB, Guerriero S, Paoletti AM, et al. Diagnosis of endometriosis. Giorn It Ost Gin 2005;27:293–6
   Google Scholar
• Bird C, McElin T, Manalo-Estrella P. The elusive adenomyosis of the uterus revisited. Am J Obstet Gynecol 1972;112:583–93
   PubMed Web of Science ®Google Scholar
• Locci R, Nisolle M, Angioni S, et al. Expression of the gamma 2 chain of laminin-332 in eutopic and ectopic endometrium of patients with endometriosis. Reprod Biol Endocrinol 2013;11:94
   PubMed Web of Science ®Google Scholar
• Di Donato N, Montanari G, Benfenati A, et al. Prevalence of adenomyosis in women undergoing surgery for endometriosis. Eur J Obstet Gynecol Reprod Biol 2014;181:289–93
   PubMed Web of Science ®Google Scholar
• Melis I, Agus M, Pluchino N, et al. Alexithymia in women with deep endometriosis? A pilot study. J Endometriosis Pelvic Pain Dis 2014;6:26–33
   Google Scholar
• Melis I, Litta P, Nappi L, et al. Sexual Function in women with deep endometriosis: correlation with quality of life, intensity of pain, depression, anxiety and body image. Intern J Sex Health 2015;27:175–85
   Web of Science ®Google Scholar
• Benson RC, Sneeden VD. Adenomyosis: a reappraisal of symptomatology. Am J Obstet Gynecol 1958;76:1044–57
   PubMed Web of Science ®Google Scholar
• Kissler S, Hamscho N, Zangos S, et al. Uterotubal transport disorder in adenomyosis and endometriosis – a cause for infertility. BJOG 2006;113:902–8
   PubMed Web of Science ®Google Scholar
• Benaglia L, Cardellicchio L, Leonardi M, et al. Asymptomatic adenomyosis and embryo implantation in IVF cycles. Reprod Biomed Online 2014;29:606–11
   PubMed Web of Science ®Google Scholar
• Guerriero S, Ajossa S, Gerada M, et al. Diagnostic value of transvaginal “tenderness-guided” ultrasonography for the prediction of location of deep endometriosis. Hum Reprod 2008;23:2452–7
   PubMed Web of Science ®Google Scholar
• Reinhold C, Atrim M, Mehio A, et al. Diffuse uterine adenomyosis: morphologic criteria and diagnostic accuracy of endovaginal sonography. Radiology 1995;197:609–14
   PubMed Web of Science ®Google Scholar
• Brosens J, DeSouza N, Barker F, et al. Endovaginal ultrasonography in the diagnosis of adenomyosis uteri: identifying the predictive characteristics. Br J Obstet Gynaecol 1995;102:471–4
   Google Scholar
• Bazot M, Cortez A, Darai E, et al. Ultrasonography compared with magnetic resonance imaging for the diagnosis of adenomyosis: correlation with histopathology. Hum Reprod 2001;16:2427–33
   PubMed Web of Science ®Google Scholar
• Pluchino Ninni F, Angioni S, et al. Office vaginoscopic hysteroscopy in infertile women: effects of gynecologist experience, instrument size, and distention medium on patient discomfort. J Minim Invasive Gynecol 2010;17:344–50
   PubMed Web of Science ®Google Scholar
• Molinas CR, Campo R. Office hysteroscopy and adenomyosis. Best Pract Res Clin Obstet Gynaecol 2006;20:557–67
   PubMed Web of Science ®Google Scholar
• Angioni S, Pontis A, Dessole M, et al. Pain control and quality of life after laparoscopic en-block resection of deep infiltrating endometriosis (DIE) vs. incomplete surgical treatment with or without GnRHa administration after surgery. Arch Gynecol Obstet 2015;291:363–70
   PubMed Web of Science ®Google Scholar
• Angioni S, Cofelice V, Pontis A, et al. New trends of progestins treatment of endometriosis. Gynecol Endocrinol 2014;30:769–73
   PubMed Web of Science ®Google Scholar
• Angioni S, Pontis A, Pisanu A, et al. Single-port access subtotal laparoscopic hysterectomy: a prospective case-control study. J Minim Invasive Gynecol 2015;22:807–12
   PubMed Web of Science ®Google Scholar
• Gordts S, Campo R, Brosens I. Hysteroscopic diagnosis and excision of myometrial cystic adenomyosis. Gynecol Surg 2014;11:273–8
   PubMedGoogle Scholar
• Yang Z, Cao Y, Hu L, et al. Feasibility of laparoscopic high intensity focused ultrasound treatment for patients with uterine localized adenomyosis. Fertil Steril 2009;91:2338–43
   PubMed Web of Science ®Google Scholar
• Angioni S, Cofelice V, Sedda F, et al. Progestins for symptomatic endometriosis: results of clinical studies. Current Drug Therapy 2015;10:91–104
   Web of Science ®Google Scholar
• Angioni S, Nappi L, Pontis A, et al. Dienogest. A possible conservative approach in bladder endometriosis. Results of a pilot study. Gynecol Endocrinol 2015;17:1–3
   Google Scholar
• Vercellini P, Vigano P, Somigliana E, Fedele L. Endometriosis: pathogenesis and treatment. Nat Rev Endocrinol 2013;10:261–75
   PubMed Web of Science ®Google Scholar
• Barbieri RL. Danazol: molecular, endocrine, and clinical pharmacology. Prog Clin Biol Res 1990;323:241–52
   PubMedGoogle Scholar
• Beaumont H, Augood C, Duckitt K, Lethaby A. Danazol for heavy menstrual bleeding. Cochrane Database Syst Rev 2007;18:CD001017
   Google Scholar
• Igarashi M, Iizuka M, Abe Y, Ibuki Y. Novel vaginal danazol ring therapy for pelvic endometriosis, in particular deeply infiltrating endometriosis. Hum Reprod 1998;13:1952–6
   PubMed Web of Science ®Google Scholar
• Cobellis L, Razzi S, Fava A, et al. Danazol loaded intrauterine device decreases dysmenorrhea, pelvic pain, and dispareunia associated with endometriosis. Fertil Steril 2004;82:239–40
   PubMed Web of Science ®Google Scholar
• Mais V, Cossu E, Angioni S, et al. Abnormal uterine bleeding: medical treatment with vaginal danazol and five-year follow-up. J Am Assoc Gynecol Laparosc 2004;11:340–3
   PubMedGoogle Scholar
• Takebayashi T, Funjino Umeski N, et al. Danazol suspension injected into the uterine cervix of patients with adenomyosis and myoma. Preliminary study. Gyne Gynecol Obstet Invest 1995;39:207–11
   PubMed Web of Science ®Google Scholar
• Luisi S, Parazzini F, Angioni S, et al. Dienogest treatment improbe quality of life in women with endometriosis. J Endomet 2015;7:124–8
   Google Scholar
• Muneyyirci-Delale O, Chandrareddy A, Mankame S, et al. Norethindrone acetate in the medical management of adenomyosis. Pharmaceuticals (Basel) 2012;5:1120–7
   PubMedGoogle Scholar
• Fawzy M, Mesbah Y. Comparison of dienogest versus triptorelin acetate in premenopausal women with adenomyosis: a prospective clinical trial. Arch Gynecol Obstet 2015;292:1267–71
   PubMed Web of Science ®Google Scholar
• Fong Y, Singh K. Medical treatment of a grossly enlarged adenomyotic uterus with the levonorgestrel-releasing intrauterine system. Contraception 1999;60:173–5
   PubMed Web of Science ®Google Scholar
• Ozdegirmenci O, Kayikcioglu F, Akgul MA, et al. Comparison of levonorgestrel intrauterine system versus hysterectomy on efficacy and quality of life in patients with adenomyosis. Fertil Steril 2011;95:497–502
   PubMed Web of Science ®Google Scholar
• Cho S, Nam A, Kim H, et al. Clinical effects of the levonorgestrel-releasing intrauterine device in patients with adenomyosis. Am J Obstet Gynecol 2008;198:373
   PubMed Web of Science ®Google Scholar
• Sheng J, Zhang Q, Zhang J. The LNG-IUS study on adenomyosis: a 3 year follow-up study on the efficacy and side effects of the use of levonorgestrel intrauterine system for the treatment of dysmenorrhea associated with adenomyosis. Contraception 2009;79:189–93
   PubMed Web of Science ®Google Scholar
• Bragheto AM, Caserta N, Bahamondes L, Pelta CA. Effectiveness of the levonorgestrel-releasing intrauterine system in the treatment of adenomyosis diagnosed and monitored by magnetic resonance imaging. Contraception 2007;76:195–9
   PubMed Web of Science ®Google Scholar
• Park DS, Kim ML, Song T, et al. Clinical experiences of the levonorgestrel-releasing intrauterine system in patients with large symptomatic adenomyosis. Taiwan J Obstet Gynecol 2015;54:412–15
   PubMed Web of Science ®Google Scholar
• Fedele L, Bianchi S, Frontino G. Hormonal treatments for adenomyosis. Best Pract Res Clin Obstet Gynaecol 2008;22:333–9
   PubMed Web of Science ®Google Scholar
• Grow D, Filer R. Treatment of adenomyosis with long-term GnRh analogues: a case report. Obstet Gynecol 1991;78:538–9
   PubMed Web of Science ®Google Scholar
• Hirata JD, Moghissi KS, Ginsburg KA. Pregnancy after medical therapy of adenomyosis with a gonadotropin-releasing hormone agonist. Fertil Steril 1993;59:444–5
   PubMed Web of Science ®Google Scholar
• Nelson JR, Corson SL. Long-term management of adenomyosis with a gonadotropin-releasing hormone agonist: a case report. Fertil Steril 1993;59:441–3
   PubMed Web of Science ®Google Scholar
• Lin J, Sun C, Zheng H. Gonadotropin-releasing hormone agonists and laparoscopy in the treatment of adenomyosis with infertility. Chin Med J (Engl) 2000;113:442–5
   PubMed Web of Science ®Google Scholar
• Stratton P, Sinaii N, Segars J, et al. Return of chronic pelvic pain from endometriosis after raloxifene treatment: a randomized controlled trial. Obstet Gynecol 2008;111:88–96
   PubMed Web of Science ®Google Scholar
• Cohen I, Beyth Y, Tepper R, et al. Adenomyosis in postmenopausal breast cancer patients treated with tamoxifen: a new entity? Gynecol Oncol 1995;58:86–91
   PubMed Web of Science ®Google Scholar
• Wang Y, Jiang X, Wang S. The influence of mifepristone to caspase 3 expression in adenomyosis. Clin Exp Obstet Gynecol 2014;41:154–7
   PubMed Web of Science ®Google Scholar
• Kettel LM, Murphy AA, Morales AJ, et al. Treatment of endometriosis with the antiprogesterone mifepristone (RU 486). Fertil Steril 1996;65:23–8
   PubMed Web of Science ®Google Scholar
• Chwalisz K, Mattia-Goldberg C, Elger W, Edmonds A. Treatment of endometriosis with the novel selective progesterone receptor modulator (SPRM) asoprisnil. Fertil Steril 2004;82:83–4
   Web of Science ®Google Scholar
• Spitz IM. Clinical utility of progesterone receptor modulators and their effect on the endometrium. Curr Opin Obstet Gynecol 2009;21:318–24
   PubMed Web of Science ®Google Scholar
• Simpson ER, Mahendroo MS, Means GD, et al. Aromatase cytochrome P450, the enzyme responsible for estrogen biosynthesis. Endocr Rev 1994;15:342–55
   PubMed Web of Science ®Google Scholar
• Bulun SE, Simpson ER. Aromatase expression in women's cancers. Adv Exp Med Biol 2008;630:112–32
   PubMed Web of Science ®Google Scholar
• Badawy AM, Elnashar AM, Mosbah AA. Aromatase inhibitors or gonadotropin-releasing hormone agonists for the management of uterine adenomyosis: a randomized controlled trial. Acta Obstet Gynecol Scand 2012;91:489–95
   PubMed Web of Science ®Google Scholar
• Bulun SE, Sharda G, Rink J, et al. Distribution of aromatase P450 transcripts and adipose fibroblasts in the human breast. J Clin Endocrinol Metab 1996;81:1273–7
   PubMed Web of Science ®Google Scholar
• Colette S, Lousse JC, Defrere S, et al. Absence of aromatase protein and mRNA expression in endometriosis. Hum Reprod 2009;24:2133–41
   PubMed Web of Science ®Google Scholar
• Dunselman GA, Vermeulen N Becker C. et al. ESHRE guideline: management of women with endometriosis. Hum Reprod 2014;29:400–12
   PubMed Web of Science ®Google Scholar
• Litta P, Nappi L, Florio P, et al. Proposal of a modified transcervical endometrial resection (TCER) technique for menorrhagia treatment. Feasibility, efficacy, and patients' acceptability. Gynecol Surg 2014;11:165–71
   Google Scholar